Usage Information
Abstract
Influenza type A viruses (IAVs) remain an extraordinary burden to global public health and regularly circulate through human populations. This investigation describes the isolation of human mAbs from an individual with a substantial history of influenza exposure via vaccination and natural infection. From these mAbs, a clonally expanded B cell lineage was identified that recognizes the IAV neuraminidase (NA) glycoprotein and binds near the NA active site of H3N2 viruses to inhibit sialidase activity. Further characterization found that some somatically mutated members of this lineage exhibited cross-reactive binding to recombinant N1 and N9 antigens, suggesting that heterosubtypic reactivity was acquired through somatic mutation. Two candidate mAbs from this family — FluA-168 and FluA-173 — potently inhibited IAV replication in vitro and protected against lethality in vivo. The results of this study contribute to our understanding of cross-reactivity between IAV subtypes in response to diverse exposure patterns and identified 2 mAbs as potential therapeutic candidates for IAV infection.
Authors
Ty A. Sornberger, Rachael M. Wolters, Iuliia M. Gilchuk, Luke Myers, Elad Binshtein, Ryan Irving, Elaine C. Chen, Pavlo Gilchuk, Rachel S. Nargi, Rachel E. Sutton, Bethany N. Howard, Laura S. Handal, Andrew Trivette, Katherine E. Webb, Chandrahaas Kona, Eduardo Villalobos, Lauren E. Williamson, James E. Crowe Jr., Seth J. Zost
Usage data is cumulative from December 2025 through March 2026.
| Usage | JCI | PMC |
|---|---|---|
| Text version | 2,757 | 139 |
| 766 | 35 | |
| Figure | 873 | 0 |
| Supplemental data | 252 | 0 |
| Citation downloads | 101 | 0 |
| Totals | 4,749 | 174 |
| Total Views | 4,923 | |
Usage information is collected from two different sources: this site (JCI) and Pubmed Central (PMC). JCI information (compiled daily) shows human readership based on methods we employ to screen out robotic usage. PMC information (aggregated monthly) is also similarly screened of robotic usage.
Various methods are used to distinguish robotic usage. For example, Google automatically scans articles to add to its search index and identifies itself as robotic; other services might not clearly identify themselves as robotic, or they are new or unknown as robotic. Because this activity can be misinterpreted as human readership, data may be re-processed periodically to reflect an improved understanding of robotic activity. Because of these factors, readers should consider usage information illustrative but subject to change.
Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)